Talor E, Lavin P, Cipriano J, Markovic D, et al. A novel neoadjuvant immunotherapy confers improved overall survival in oral cancer patients with low tumor PD-L1 expression The IT-MATTERS Clinical trial - Prognostic role of tumor PD-L1 expression. Oral Oncol 2026;181:108092.
PMID: 42537452